 | • レポートコード：D0GIR-01084 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、T細胞リンパ腫治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。T細胞リンパ腫治療の種類別市場規模（化学療法、放射線療法、外科療法、幹細胞移植療法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：BioCryst Pharmaceuticals、Spectrum Pharmaceuticals、Merck、Johnson & Johnson、Shionogi、Novartis、Shenzhen ChipScreen Biosciences, Ltd.、Genmab AS、Bristol-Myers Squibb、Seattle Genetics、Medivir AB、Sorrento Therapeutics、Amgen、Eisai Co., Ltd. ・地域別グローバル市場分析 2015年-2020年 ・T細胞リンパ腫治療の北米市場（アメリカ、カナダ、メキシコ） ・T細胞リンパ腫治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・T細胞リンパ腫治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・T細胞リンパ腫治療の南米市場（ブラジル、アルゼンチン） ・T細胞リンパ腫治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学療法、放射線療法、外科療法、幹細胞移植療法、その他 ・用途別分析：病院、クリニック、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The T-Cell Lymphoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global T-Cell Lymphoma Treatment sales will be xx in 2020 from T-Cell Lymphoma Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global T-Cell Lymphoma Treatment market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the T-Cell Lymphoma Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on T-Cell Lymphoma Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
T-Cell Lymphoma Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, T-Cell Lymphoma Treatment market has been segmented into:
Chemotherapy
Radiation Therapy
Surgical Therapy
Stem Cell Transplantation Therapy
Others
By Application, T-Cell Lymphoma Treatment has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global T-Cell Lymphoma Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level T-Cell Lymphoma Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global T-Cell Lymphoma Treatment market.
The report offers in-depth assessment of the growth and other aspects of the T-Cell Lymphoma Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and T-Cell Lymphoma Treatment Market Share Analysis
T-Cell Lymphoma Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, T-Cell Lymphoma Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the T-Cell Lymphoma Treatment sales, revenue and market share for each player covered in this report.
The major players covered in T-Cell Lymphoma Treatment are:
BioCryst Pharmaceuticals
Spectrum Pharmaceuticals
Merck
Johnson & Johnson
Shionogi
Novartis
Shenzhen ChipScreen Biosciences, Ltd.
Genmab AS
Bristol-Myers Squibb
Seattle Genetics
Medivir AB
Sorrento Therapeutics
Amgen
Eisai Co., Ltd.
Among other players domestic and global, T-Cell Lymphoma Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 T-Cell Lymphoma Treatment Market Overview
1.1 Product Overview and Scope of T-Cell Lymphoma Treatment
1.2 Classification of T-Cell Lymphoma Treatment by Therapy
1.2.1 Global T-Cell Lymphoma Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global T-Cell Lymphoma Treatment Revenue Market Share by Therapy in 2019
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.2.5 Surgical Therapy
1.2.6 Stem Cell Transplantation Therapy
1.2.7 Others
1.3 Global T-Cell Lymphoma Treatment Market by End Users
1.3.1 Overview: Global T-Cell Lymphoma Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global T-Cell Lymphoma Treatment Market by Regions
1.4.1 Global T-Cell Lymphoma Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of T-Cell Lymphoma Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) T-Cell Lymphoma Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) T-Cell Lymphoma Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) T-Cell Lymphoma Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) T-Cell Lymphoma Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) T-Cell Lymphoma Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: T-Cell Lymphoma Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the T-Cell Lymphoma Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on T-Cell Lymphoma Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 BioCryst Pharmaceuticals
2.1.1 BioCryst Pharmaceuticals Details
2.1.2 BioCryst Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 BioCryst Pharmaceuticals SWOT Analysis
2.1.4 BioCryst Pharmaceuticals Product and Services
2.1.5 BioCryst Pharmaceuticals T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Spectrum Pharmaceuticals
2.2.1 Spectrum Pharmaceuticals Details
2.2.2 Spectrum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Spectrum Pharmaceuticals SWOT Analysis
2.2.4 Spectrum Pharmaceuticals Product and Services
2.2.5 Spectrum Pharmaceuticals T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shionogi
2.5.1 Shionogi Details
2.5.2 Shionogi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shionogi SWOT Analysis
2.5.4 Shionogi Product and Services
2.5.5 Shionogi T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shenzhen ChipScreen Biosciences, Ltd.
2.7.1 Shenzhen ChipScreen Biosciences, Ltd. Details
2.7.2 Shenzhen ChipScreen Biosciences, Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Shenzhen ChipScreen Biosciences, Ltd. SWOT Analysis
2.7.4 Shenzhen ChipScreen Biosciences, Ltd. Product and Services
2.7.5 Shenzhen ChipScreen Biosciences, Ltd. T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genmab AS
2.8.1 Genmab AS Details
2.8.2 Genmab AS Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genmab AS SWOT Analysis
2.8.4 Genmab AS Product and Services
2.8.5 Genmab AS T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bristol-Myers Squibb
2.9.1 Bristol-Myers Squibb Details
2.9.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bristol-Myers Squibb SWOT Analysis
2.9.4 Bristol-Myers Squibb Product and Services
2.9.5 Bristol-Myers Squibb T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Seattle Genetics
2.10.1 Seattle Genetics Details
2.10.2 Seattle Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Seattle Genetics SWOT Analysis
2.10.4 Seattle Genetics Product and Services
2.10.5 Seattle Genetics T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Medivir AB
2.11.1 Medivir AB Details
2.11.2 Medivir AB Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Medivir AB SWOT Analysis
2.11.4 Medivir AB Product and Services
2.11.5 Medivir AB T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sorrento Therapeutics
2.12.1 Sorrento Therapeutics Details
2.12.2 Sorrento Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sorrento Therapeutics SWOT Analysis
2.12.4 Sorrento Therapeutics Product and Services
2.12.5 Sorrento Therapeutics T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Amgen
2.13.1 Amgen Details
2.13.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Amgen SWOT Analysis
2.13.4 Amgen Product and Services
2.13.5 Amgen T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Eisai Co., Ltd.
2.14.1 Eisai Co., Ltd. Details
2.14.2 Eisai Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Eisai Co., Ltd. SWOT Analysis
2.14.4 Eisai Co., Ltd. Product and Services
2.14.5 Eisai Co., Ltd. T-Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global T-Cell Lymphoma Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 T-Cell Lymphoma Treatment Players Market Share
3.2.2 Top 10 T-Cell Lymphoma Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global T-Cell Lymphoma Treatment Revenue and Market Share by Regions
4.2 North America T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
4.5 South America T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
5 North America T-Cell Lymphoma Treatment Revenue by Countries
5.1 North America T-Cell Lymphoma Treatment Revenue by Countries (2015-2020)
5.2 USA T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
6 Europe T-Cell Lymphoma Treatment Revenue by Countries
6.1 Europe T-Cell Lymphoma Treatment Revenue by Countries (2015-2020)
6.2 Germany T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
6.3 UK T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
6.4 France T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific T-Cell Lymphoma Treatment Revenue by Countries
7.1 Asia-Pacific T-Cell Lymphoma Treatment Revenue by Countries (2015-2020)
7.2 China T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
7.5 India T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
8 South America T-Cell Lymphoma Treatment Revenue by Countries
8.1 South America T-Cell Lymphoma Treatment Revenue by Countries (2015-2020)
8.2 Brazil T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue T-Cell Lymphoma Treatment by Countries
9.1 Middle East & Africa T-Cell Lymphoma Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global T-Cell Lymphoma Treatment Revenue and Market Share by Therapy (2015-2020)
10.2 Global T-Cell Lymphoma Treatment Market Forecast by Therapy (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Radiation Therapy Revenue Growth Rate (2015-2025)
10.5 Surgical Therapy Revenue Growth Rate (2015-2025)
10.6 Stem Cell Transplantation Therapy Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global T-Cell Lymphoma Treatment Market Segment by End Users
11.1 Global T-Cell Lymphoma Treatment Revenue Market Share by End Users (2015-2020)
11.2 T-Cell Lymphoma Treatment Market Forecast by End Users (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global T-Cell Lymphoma Treatment Market Size Forecast (2021-2025)
12.1 Global T-Cell Lymphoma Treatment Market Size Forecast (2021-2025)
12.2 Global T-Cell Lymphoma Treatment Market Forecast by Regions (2021-2025)
12.3 North America T-Cell Lymphoma Treatment Revenue Market Forecast (2021-2025)
12.4 Europe T-Cell Lymphoma Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific T-Cell Lymphoma Treatment Revenue Market Forecast (2021-2025)
12.6 South America T-Cell Lymphoma Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa T-Cell Lymphoma Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global T-Cell Lymphoma Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of T-Cell Lymphoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global T-Cell Lymphoma Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market T-Cell Lymphoma Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global T-Cell Lymphoma Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. BioCryst Pharmaceuticals Corporate Information, Location and Competitors
Table 7. BioCryst Pharmaceuticals T-Cell Lymphoma Treatment Major Business
Table 8. BioCryst Pharmaceuticals T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 9. BioCryst Pharmaceuticals SWOT Analysis
Table 10. BioCryst Pharmaceuticals T-Cell Lymphoma Treatment Product and Solutions
Table 11. BioCryst Pharmaceuticals T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Spectrum Pharmaceuticals Corporate Information, Location and Competitors
Table 13. Spectrum Pharmaceuticals T-Cell Lymphoma Treatment Major Business
Table 14. Spectrum Pharmaceuticals T-Cell Lymphoma Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Spectrum Pharmaceuticals SWOT Analysis
Table 16. Spectrum Pharmaceuticals T-Cell Lymphoma Treatment Product and Solutions
Table 17. Spectrum Pharmaceuticals T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Merck Corporate Information, Location and Competitors
Table 19. Merck T-Cell Lymphoma Treatment Major Business
Table 20. Merck T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Merck SWOT Analysis
Table 22. Merck T-Cell Lymphoma Treatment Product and Solutions
Table 23. Merck T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Johnson & Johnson Corporate Information, Location and Competitors
Table 25. Johnson & Johnson T-Cell Lymphoma Treatment Major Business
Table 26. Johnson & Johnson T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Johnson & Johnson SWOT Analysis
Table 28. Johnson & Johnson T-Cell Lymphoma Treatment Product and Solutions
Table 29. Johnson & Johnson T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Shionogi Corporate Information, Location and Competitors
Table 31. Shionogi T-Cell Lymphoma Treatment Major Business
Table 32. Shionogi T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Shionogi SWOT Analysis
Table 34. Shionogi T-Cell Lymphoma Treatment Product and Solutions
Table 35. Shionogi T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Novartis Corporate Information, Location and Competitors
Table 37. Novartis T-Cell Lymphoma Treatment Major Business
Table 38. Novartis T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Novartis SWOT Analysis
Table 40. Novartis T-Cell Lymphoma Treatment Product and Solutions
Table 41. Novartis T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Shenzhen ChipScreen Biosciences, Ltd. Corporate Information, Location and Competitors
Table 43. Shenzhen ChipScreen Biosciences, Ltd. T-Cell Lymphoma Treatment Major Business
Table 44. Shenzhen ChipScreen Biosciences, Ltd. T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 45. Shenzhen ChipScreen Biosciences, Ltd. SWOT Analysis
Table 46. Shenzhen ChipScreen Biosciences, Ltd. T-Cell Lymphoma Treatment Product and Solutions
Table 47. Shenzhen ChipScreen Biosciences, Ltd. T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Genmab AS Corporate Information, Location and Competitors
Table 49. Genmab AS T-Cell Lymphoma Treatment Major Business
Table 50. Genmab AS T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Genmab AS SWOT Analysis
Table 52. Genmab AS T-Cell Lymphoma Treatment Product and Solutions
Table 53. Genmab AS T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 55. Bristol-Myers Squibb T-Cell Lymphoma Treatment Major Business
Table 56. Bristol-Myers Squibb T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 57. Bristol-Myers Squibb SWOT Analysis
Table 58. Bristol-Myers Squibb T-Cell Lymphoma Treatment Product and Solutions
Table 59. Bristol-Myers Squibb T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Seattle Genetics Corporate Information, Location and Competitors
Table 61. Seattle Genetics T-Cell Lymphoma Treatment Major Business
Table 62. Seattle Genetics T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 63. Seattle Genetics SWOT Analysis
Table 64. Seattle Genetics T-Cell Lymphoma Treatment Product and Solutions
Table 65. Seattle Genetics T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Medivir AB Corporate Information, Location and Competitors
Table 67. Medivir AB T-Cell Lymphoma Treatment Major Business
Table 68. Medivir AB T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 69. Medivir AB SWOT Analysis
Table 70. Medivir AB T-Cell Lymphoma Treatment Product and Solutions
Table 71. Medivir AB T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Sorrento Therapeutics Corporate Information, Location and Competitors
Table 73. Sorrento Therapeutics T-Cell Lymphoma Treatment Major Business
Table 74. Sorrento Therapeutics T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 75. Sorrento Therapeutics SWOT Analysis
Table 76. Sorrento Therapeutics T-Cell Lymphoma Treatment Product and Solutions
Table 77. Sorrento Therapeutics T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Amgen Corporate Information, Location and Competitors
Table 79. Amgen T-Cell Lymphoma Treatment Major Business
Table 80. Amgen T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 81. Amgen SWOT Analysis
Table 82. Amgen T-Cell Lymphoma Treatment Product and Solutions
Table 83. Amgen T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Eisai Co., Ltd. Corporate Information, Location and Competitors
Table 85. Eisai Co., Ltd. T-Cell Lymphoma Treatment Major Business
Table 86. Eisai Co., Ltd. T-Cell Lymphoma Treatment Total Revenue (USD Million) (2017-2018)
Table 87. Eisai Co., Ltd. SWOT Analysis
Table 88. Eisai Co., Ltd. T-Cell Lymphoma Treatment Product and Solutions
Table 89. Eisai Co., Ltd. T-Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Global T-Cell Lymphoma Treatment Revenue (Million USD) by Players (2015-2020)
Table 91. Global T-Cell Lymphoma Treatment Revenue Share by Players (2015-2020)
Table 92. Global T-Cell Lymphoma Treatment Revenue (Million USD) by Regions (2015-2020)
Table 93. Global T-Cell Lymphoma Treatment Revenue Market Share by Regions (2015-2020)
Table 94. North America T-Cell Lymphoma Treatment Revenue by Countries (2015-2020)
Table 95. North America T-Cell Lymphoma Treatment Revenue Market Share by Countries (2015-2020)
Table 96. Europe T-Cell Lymphoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 97. Asia-Pacific T-Cell Lymphoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 98. South America T-Cell Lymphoma Treatment Revenue by Countries (2015-2020)
Table 99. South America T-Cell Lymphoma Treatment Revenue Market Share by Countries (2015-2020)
Table 100. Middle East and Africa T-Cell Lymphoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 101. Middle East and Africa T-Cell Lymphoma Treatment Revenue Market Share by Countries (2015-2020)
Table 102. Global T-Cell Lymphoma Treatment Revenue (Million USD) by Type (2015-2020)
Table 103. Global T-Cell Lymphoma Treatment Revenue Share by Type (2015-2020)
Table 104. Global T-Cell Lymphoma Treatment Revenue Forecast by Type (2021-2025)
Table 105. Global T-Cell Lymphoma Treatment Revenue by Application (2015-2020)
Table 106. Global T-Cell Lymphoma Treatment Revenue Share by Application (2015-2020)
Table 107. Global T-Cell Lymphoma Treatment Revenue Forecast by Application (2021-2025)
Table 108. Global T-Cell Lymphoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. T-Cell Lymphoma Treatment Picture
Figure 2. Global T-Cell Lymphoma Treatment Revenue Market Share by Therapy in 2019
Figure 3. Chemotherapy Picture
Figure 4. Radiation Therapy Picture
Figure 5. Surgical Therapy Picture
Figure 6. Stem Cell Transplantation Therapy Picture
Figure 7. Others Picture
Figure 8. T-Cell Lymphoma Treatment Revenue Market Share by End Users in 2019
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Ambulatory Surgical Centers Picture
Figure 12. Others Picture
Figure 13. Global T-Cell Lymphoma Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America T-Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe T-Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific T-Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America T-Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa T-Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global T-Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global T-Cell Lymphoma Treatment Revenue Share by Players in 2019
Figure 21. Global Top 5 Players T-Cell Lymphoma Treatment Revenue Market Share in 2019
Figure 22. Global Top 10 Players T-Cell Lymphoma Treatment Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global T-Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global T-Cell Lymphoma Treatment Revenue Market Share by Regions (2015-2020)
Figure 26. Global T-Cell Lymphoma Treatment Revenue Market Share by Regions in 2018
Figure 27. North America T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Europe T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 30. South America T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 32. North America T-Cell Lymphoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. North America T-Cell Lymphoma Treatment Revenue Market Share by Countries in 2019
Figure 34. USA T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Canada T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Mexico T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Europe T-Cell Lymphoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 38. Europe T-Cell Lymphoma Treatment Revenue Market Share by Countries in 2019
Figure 39. Germany T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 40. UK T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 41. France T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Russia T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Italy T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific T-Cell Lymphoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific T-Cell Lymphoma Treatment Revenue Market Share by Countries in 2019
Figure 46. China T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Japan T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Korea T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 49. India T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 51. South America T-Cell Lymphoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. South America T-Cell Lymphoma Treatment Revenue Market Share by Countries in 2019
Figure 53. Brazil T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Argentina T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa T-Cell Lymphoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa T-Cell Lymphoma Treatment Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 58. UAE T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Egypt T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 60. South Africa T-Cell Lymphoma Treatment Revenue and Growth Rate (2015-2020)
Figure 61. Global T-Cell Lymphoma Treatment Revenue Share by Type (2015-2020)
Figure 62. Global T-Cell Lymphoma Treatment Revenue Share by Type in 2019
Figure 63. Global T-Cell Lymphoma Treatment Market Share Forecast by Type (2021-2025)
Figure 64. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 65. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 66. Global Surgical Therapy Revenue Growth Rate (2015-2020)
Figure 67. Global Stem Cell Transplantation Therapy Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global T-Cell Lymphoma Treatment Revenue Share by Application (2015-2020)
Figure 70. Global T-Cell Lymphoma Treatment Revenue Share by Application in 2019
Figure 71. Global T-Cell Lymphoma Treatment Market Share Forecast by Application (2021-2025)
Figure 72. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 73. Global Clinics Revenue Growth Rate (2015-2020)
Figure 74. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global T-Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global T-Cell Lymphoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global T-Cell Lymphoma Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America T-Cell Lymphoma Treatment Revenue Market Forecast (2021-2025)
Figure 80. Europe T-Cell Lymphoma Treatment Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific T-Cell Lymphoma Treatment Revenue Market Forecast (2021-2025)
Figure 82. South America T-Cell Lymphoma Treatment Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa T-Cell Lymphoma Treatment Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
皮膚B細胞リンパ腫治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cutaneous B-Cell Lymphoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…- B細胞性非ホジキンリンパ腫（NHL）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 末梢T細胞リンパ腫（PTCL）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Peripheral T-Cell Lymphoma (PTCL) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 皮膚T細胞リンパ腫（CTCL）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cutaneous T-Cell Lymphoma (CTCL) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…
- 血管免疫芽球性T細胞リンパ腫（AILT）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market play…